Gene therapies been re-branded 'advanced therapies'—the feeding frenzy continues
Even FDAs top vaccine guy, Peter Marks, is in on it!
Keep getting this advanced therapy conference in my mailbox
Every few weeks, I get an email from Terrapinn, asking me to buy a ticket for their 2024 conference on advanced therapies. The speaker list is below:
Advanced Therapies 2024, 19-20th March, ExCeL London
Scroll down to speakers with the name beginning with ‘M’, and you will see Peter Marks M.D., PhD., Director - Center for Biologics Evaluation and Research (CBER) .
Marks is the person with delegated authority to evaluate and research applications to market new biologics drugs, eg vaccines.
Could this just be a teenty weeny conflict of interest?
Not at all, it’s a massive one!!!
It is also unprecedented for someone in his position to do anything other than fly-in for a Keynote Address, then fly out again. Hobobbing with the regulated was always a no-no.
What about the other speakers?
Now check out the other speakers. Take it from me, none of them have a clue about the complexities of manufacturing and distributing complex biologic pro…